Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jan 1;17(1):164.
doi: 10.3390/nu17010164.

High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls

Affiliations
Randomized Controlled Trial

High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls

Wissal Abassi et al. Nutrients. .

Abstract

Background/objectives: Despite the abundant body of evidence linking high-intensity interval training (HIIT) to cardiometabolic markers, little is known about how HIIT affects liver enzymes, particularly in obese adolescents. This study aimed to investigate the effects of HIIT on metabolic dysfunction-associated steatotic liver disease (MASLD)-related biomarkers in overweight/obese adolescent girls.

Methods: Thirty-three overweight/obese adolescent girls (age, 17.0 ± 1.15 yr.; body mass index, 33.3 ± 4.77 kg/m2) were randomly assigned to HIIT (n = 17) or control (n = 16) groups. The HIIT group participated in a nine-week HIIT program (three times weekly) without caloric restriction. Maximal aerobic speed, body composition indexes, blood pressure, MASLD-related biomarkers [liver enzymes (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)), plasma lipids, uric acid, platelet count, and homeostasis model assessment index for insulin-resistance (HOMA-IR)] were examined at baseline and after the intervention.

Results: Significant "time × group" interactions were found for body composition indexes, systolic blood pressure, maximal aerobic speed, liver enzymes ALT and AST, plasma lipids, glucose, and HOMA-IR. The HIIT program resulted in an increase in maximal aerobic speed (p = 0.035) and a decrease in body composition and plasma lipids (p < 0.01), systolic blood pressure (p = 0.011), ALT (p = 0.013), AST (p = 0.012), and HOMA-IR (p = 0.01), but no significant changes in uric acid and platelet count. None of these markers changed in the control group.

Conclusions: HIIT resulted in an improvement in MASLD-related biomarkers. HIIT could be an effective exercise therapy to prevent and reverse MASLD in adolescents with obesity.

Keywords: insulin resistance; lipid profile; liver enzyme; nonalcoholic fatty liver disease; obesity; physical training.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of study. HIIT, high-intensity interval training.
Figure 2
Figure 2
Changes in anthropometric, biochemical, and physical variables following a nine-week intervention program in high-intensity interval training (HIIT) and control (CG) groups. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BM, body mass; BF, body fat percentage; HDL-C, HDL-cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; LDL-C, LDL-cholesterol; MAS, maximal aerobic speed; SBP, systolic blood pressure; TG, triglyceride; WC, waist circumference. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (compared to control group; t-test for independent samples).

Similar articles

Cited by

References

    1. Rinella M.E., Lazarus J.V., Ratziu V., Francque S.M., Sanyal A.J., Kanwal F., Romero D., Abdelmalek M.F., Anstee Q.M., Arab J.P., et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 2023;79:1542–1556. doi: 10.1016/j.jhep.2023.06.003. - DOI - PubMed
    1. van Son K.C., Te Nijenhuis-Noort L.C., Boone S.C., Mook-Kanamori D.O., Holleboom A.G., Roos P.R., Lamb H.J., Alblas G., Coenraad M.J., Rosendaal F.R., et al. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine. 2024;103:e34934. doi: 10.1097/MD.0000000000034934. - DOI - PMC - PubMed
    1. Anderson E.L., Howe L.D., Jones H.E., Higgins J.P., Lawlor D.A., Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS ONE. 2015;10:e0140908. doi: 10.1371/journal.pone.0140908. - DOI - PMC - PubMed
    1. Guijarro de Armas M.G., Monereo Megías S., Navea Aguilera C., Merino Viveros M., Vega Piñero M.B. Non-alcoholic fatty liver in children and adolescents with excess weight and obesity. Med. Clin. 2015;144:55–58. doi: 10.1016/j.medcli.2014.02.018. - DOI - PubMed
    1. Younossi Z.M., Kalligeros M., Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 2024 doi: 10.3350/cmh.2024.0431. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources